Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Knowing when to switch from aggressive to conservative investing is key. Understand the signs that indicate it's time to adjust your strategy.
14,591 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
A closer look at JEPQ reveals a persistent gap between monthly income and total returns. The premium income ETF pays ...
A new income strategy built on equal weighted dividends across 54 stocks has posted 24.7% returns over the last year ...
A staffing collapse at the federal loan arm coincides with policy shifts that cap borrowing and alter repayment. Borr...
Tech stocks just their footing as an AI spending surge loses steam. The sector faced a rough week, driven by slower d...
Qualcomm is pivoting from phones to AI chips and software, aiming to blend edge intelligence with data-center power. ...
A sharp global copper crunch boosts Freeport-McMoRan as the leading domestic copper king. Investors eye FCX for cash ...
Harvest Capital and TPG Credit have closed a $600 million recapitalization line for Metro Development Group, enabling...
France faces a sharp rise in crypto related abductions, forcing authorities to trace the personal data criminals expl...
Former Fed governor Kevin Warsh signals a slower pace for shrinking the Fed's balance sheet, focusing policymakers on...
JPMorgan warns that Michael Saylor’s aggressive BTC purchases, financed through complex instruments, could become a f...
Micron's strategy will face a sweeping test as two giants in the memory market push forward with enormous spending. T...